NEEDHAM, Mass., Aug. 18, 2025 /PRNewswire/ -- Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for ...
Stealth Security recognized for being innovative, impactful, and intriguing in application and data security MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–May 10, 2018– Stealth Security, an innovator in the ...
BLUE BELL, Pa., Sept. 30, 2019 /PRNewswire/ -- Unisys Corporation (NYSE: UIS) today announced that its award-winning Unisys Stealth® security software suite now leverages the new Microsoft Azure ...
Dublin, Sept. 02, 2022 (GLOBE NEWSWIRE) -- The "Stealth Coating Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com ...
After an FDA rejection in May, Stealth BioTherapeutics has resubmitted a new drug application for its investigational treatment designed to treat an ultra-rare genetic disease. This is the biotech’s ...
The FDA has accepted Stealth BioTherapeutics’ new drug application for its ultrarare disease candidate, providing a planned decision date of Sept. 26. The timeline is surprising since the agency ...
LightStep, a company which has developed a new tool for application performance management, has emerged from stealth with a $29 million dollar war chest. The company, founded by ex-Google engineer Ben ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results